Seeking Alpha

ISS and Glass Lewis recommend voting in favor of all proposals at Teva's upcoming shareholder meeting

  • Leading proxy advisory firms ISS and Glass Lewis both recommend shareholders vote in favor of all proposals for Teva Pharmaceuticals' (TEVA) annual meeting.
  • After a thorough analysis of Teva's compensation policy, Glass Lewis stated: "Overall, the Company has provided adequate disclosure regarding its executive compensation program. We have not identified any significant issues for shareholder concern and believe that the company has designed appropriate incentive plans that will link pay for performance going forward."
  • Shares +0.5% AH.
Comments (3)
  • doc47
    , contributor
    Comments (992) | Send Message
     
    Why?? They have done almost nothing right and the stock performance is near disaster level. Even if the proposals make sense, I'd vote against the management.
    14 Aug 2013, 04:25 PM Reply Like
  • California Dividend Bull
    , contributor
    Comments (137) | Send Message
     
    I already voted against this proposal. Not so much because I lacked transparency but why would any CEO in the world need to get paid a several million dollar bonus on top of salary? A bonus is an incentive for making an extraordinary job, not a part of a too generous overall compensation. Here goes my money. I'd rather have these boni paid out as special dividends to the shareholders or used in the next inevitable litigation...
    14 Aug 2013, 04:39 PM Reply Like
  • Marius1998
    , contributor
    Comment (1) | Send Message
     
    The stock price is indeed rather disappointing but the dividends are stable. I would give them a chance to come up with a serious plan in order to compensate for the loss of copaxone in the near future.
    14 Aug 2013, 11:31 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|